Lipoxin A4

Lipoxin a4 is a lipid of Fatty Acyls (FA) class. Lipoxin a4 is associated with abnormalities such as Asthma, Cystic Fibrosis, Pneumonia, Obesity and Septicemia. The involved functions are known as Inflammation, Signal, Signal Transduction, Regulation and Metabolic Inhibition. Lipoxin a4 often locates in Immune system, Blood, soluble, Extracellular and Splenic Tissue. The associated genes with Lipoxin A4 are FPR2 gene, Homologous Gene, SAA1 gene, Trp-Lys-Tyr-Met-Val-Met and Annexin 1. The related lipids are Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Lipoxin A4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Lipoxin A4?

Lipoxin A4 is suspected in Asthma, Cystic Fibrosis, Chagas Cardiomyopathy, Pneumonia, Obesity, Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Lipoxin A4

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Diseases D008171 37 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 53

PubChem Associated disorders and diseases

What pathways are associated with Lipoxin A4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Lipoxin A4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Lipoxin A4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Lipoxin A4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Lipoxin A4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Lipoxin A4?

Knock-out

Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Lipoxin A4

Download all related citations
Per page 10 20 50 100 | Total 639
Authors Title Published Journal PubMed Link
Wu SH et al. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. 2009 Am. J. Pathol. pmid:19095947
Calandria JM et al. Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. 2009 J. Biol. Chem. pmid:19403949
Baker N et al. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. 2009 J. Immunol. pmid:19265161
Zurier RB et al. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. 2009 FASEB J. pmid:19124557
Kupczyk M et al. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model. 2009 Allergy pmid:19385948
Perretti M and D'Acquisto F Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. 2009 Nat. Rev. Immunol. pmid:19104500
El Kebir D et al. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. 2009 Am. J. Respir. Crit. Care Med. pmid:19483113
Li G et al. The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening. 2009 BMC Musculoskelet Disord pmid:19490628
Chen Q et al. The inhibitory effect of 15-R-LXA4 on experimental endometriosis. 2009 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:19523744
Ereso AQ et al. Lipoxin a(4) attenuates microvascular fluid leak during inflammation. 2009 J. Surg. Res. pmid:19524267
Liu S et al. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. 2009 Pharmacology pmid:19478549
Morris T et al. Effects of low-dose aspirin on acute inflammatory responses in humans. 2009 J. Immunol. pmid:19597002
Divangahi M et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. 2009 Nat. Immunol. pmid:19561612
Liu SJ et al. [Protective effects and its mechanism of lipoxins on human umbilical vein endothelial cells under hypoxia]. 2009 Zhonghua Fu Chan Ke Za Zhi pmid:19570467
Martins V et al. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. 2009 J. Immunol. pmid:19380784
Karim MJ et al. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats. 2009 J Ocul Pharmacol Ther pmid:20021273
Wu SH et al. Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura. 2009 Prostaglandins Leukot. Essent. Fatty Acids pmid:19264468
Li YS et al. Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC. 2008 Arch. Biochem. Biophys. pmid:18652801
Wu SH et al. Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide. 2008 Inflamm. Res. pmid:18777114
Ye Y et al. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. 2008 J. Immunol. pmid:18714024
Starosta V et al. Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes. 2008 J. Immunol. pmid:19050289
Chen M et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. 2008 J. Exp. Med. pmid:18955568
Menzies D et al. Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. 2008 J. Allergy Clin. Immunol. pmid:18313127
Petasis NA et al. Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. 2008 Bioorg. Med. Chem. Lett. pmid:18249111
Cezar-de-Mello PF et al. ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. 2008 Br. J. Pharmacol. pmid:18193074
Tahan F et al. The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma. 2008 J Asthma pmid:18350409
Merched AJ et al. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. 2008 FASEB J. pmid:18559988
Haworth O et al. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. 2008 Nat. Immunol. pmid:18568027
El Kebir D et al. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. 2008 J. Leukoc. Biol. pmid:18495783
Weinberger B et al. Mechanisms mediating reduced responsiveness of neonatal neutrophils to lipoxin A4. 2008 Pediatr. Res. pmid:18535486
Chiron R et al. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy. 2008 J. Cyst. Fibros. pmid:18541460
Planagumà A et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. 2008 Am. J. Respir. Crit. Care Med. pmid:18583575
Kim DM et al. The effect of aspirin on gingival crevicular fluid levels of inflammatory and anti-inflammatory mediators in patients with gingivitis. 2007 J. Periodontol. pmid:17668982
Biteman B et al. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. 2007 FASEB J. pmid:17384141
Weylandt KH et al. Lipoxins and resolvins in inflammatory bowel disease. 2007 Inflamm. Bowel Dis. pmid:17262807
Wu SH et al. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17329090
Celik GE et al. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. 2007 Clin. Exp. Allergy pmid:17883729
Hashimoto A et al. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. 2007 J. Rheumatol. pmid:17918787
O'Sullivan TP et al. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. 2007 J. Med. Chem. pmid:17960922
El-Sharkawy H et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. 2007 J. Periodontol. pmid:17397313
El Kebir D et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. 2007 J. Immunol. pmid:17579083
Bonnans C et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. 2007 Biomed. Pharmacother. pmid:17418999
Peres CM et al. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. 2007 Microbes Infect. pmid:17347013
Zhang L et al. Lipoxin A4 negatively regulates lipopolysaccharide-induced differentiation of RAW264.7 murine macrophages into dendritic-like cells. 2007 Chin. Med. J. pmid:17624266
Levy BD et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. 2007 FASEB J. pmid:17625069
Birnbaum Y et al. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. 2007 Prostaglandins Other Lipid Mediat. pmid:17259075
Souza DG et al. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. 2007 J. Immunol. pmid:18056401
Zhou XY et al. Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretion. 2007 Inflamm. Res. pmid:17687517
Rao NL et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. 2007 J. Pharmacol. Exp. Ther. pmid:17371808
Hashimoto A et al. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation. 2007 Biomed. Pharmacother. pmid:17184966